1. Home
  2. BBSI vs MNKD Comparison

BBSI vs MNKD Comparison

Compare BBSI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$29.16

Market Cap

711.6M

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$2.67

Market Cap

793.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBSI
MNKD
Founded
1965
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.6M
793.6M
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
BBSI
MNKD
Price
$29.16
$2.67
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$42.67
$8.56
AVG Volume (30 Days)
233.8K
4.6M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.10%
N/A
EPS Growth
5.05
N/A
EPS
2.08
0.02
Revenue
$920,432,000.00
$348,966,000.00
Revenue This Year
$6.59
$35.81
Revenue Next Year
$6.05
$11.89
P/E Ratio
$13.99
$131.75
Revenue Growth
9.50
22.23
52 Week Low
$25.33
$2.23
52 Week High
$49.65
$6.51

Technical Indicators

Market Signals
Indicator
BBSI
MNKD
Relative Strength Index (RSI) 48.38 42.09
Support Level $28.11 $2.52
Resistance Level $29.49 $6.18
Average True Range (ATR) 1.05 0.12
MACD 0.13 0.11
Stochastic Oscillator 60.37 97.78

Price Performance

Historical Comparison
BBSI
MNKD

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: